Malaysia withdraws draft medtech regulations due to procedural errors
This article was originally published in Clinica
The Malaysian Medical Device Authority has withdrawn the draft regulations it had issued for stakeholder consultation on 8 August in which it had explained its plans for implementing the provisions of the Medical Device Act 2012.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.